Biosurgery market expands with rising surgical volumes, aging populations, and increasing adoption of advanced surgical biomaterials.
Lifescience & Healthcare
Biosurgery market expands with rising surgical volumes, aging populations, and increasing adoption of advanced surgical biomaterials.
The global biosurgery market is witnessing significant growth as healthcare systems increasingly adopt advanced surgical biomaterials to improve patient outcomes, reduce complications, and enhance surgical efficiency. Biosurgery encompasses a broad range of biologically derived and bio-compatible materialsincluding hemostatic agents, surgical sealants and adhesives, bone-graft substitutes, adhesion barriers, soft-tissue attachments, and staple-line reinforcement productsthat assist in surgical procedures by controlling bleeding, sealing tissues, promoting regeneration, and preventing postoperative complications.
Biosurgical products are widely used across multiple surgical specialties, including orthopedic surgery, general surgery, cardiovascular surgery, neurological surgery, reconstructive surgery, gynecological surgery, urological surgery, and thoracic surgery. These products are utilized among patients undergoing joint replacement, spinal fusion, trauma repair, cardiac procedures, and various other surgical interventions.
According to the research report, "Global Biosurgery Market Outlook, 2031," published by Bonafide Research, the Global Biosurgery Market is expected to cross USD 25.08 Billion market size by 2031, with 6.13% CAGR from 2026 to 2031. The global biosurgery market is projected to expand significantly during the forecast period from 2026 to 2031, supported by the rising global burden of chronic diseases, increasing surgical procedure volumes, growing elderly population, technological advancements in surgical biomaterials, and improving access to specialized surgical care.
According to the World Health Organization (WHO), an estimated 313 million surgical procedures are performed globally each year. Surgical conditions contribute to approximately 30% of the global burden of disease. According to the WHO, the global population aged 60 years and older is expected to reach 2.1 billion by 2050, significantly increasing demand for orthopedic and other surgical interventions. According to the International Diabetes Federation (IDF), approximately 537 million adults were living with diabetes globally in 2021, and this number is projected to rise to 643 million by 2030, directly increasing demand for biosurgery products in wound care and surgical management.
Rising Burden of Chronic Diseases and Surgical Procedures Driving Biosurgery Market Expansion
The increasing global prevalence of chronic diseases represents the primary growth driver for the biosurgery market. Aging populations across North America, Europe, and Asia-Pacific are contributing significantly to the rising number of patients requiring surgical interventions. Additionally, improvements in healthcare delivery have increased access to surgical care, resulting in a larger population undergoing surgical procedures globally.
Biosurgical products have become an essential component of modern surgical care by improving hemostasis, reducing postoperative complications, accelerating wound healing, and lowering the risk of surgical site infections among appropriately selected patients. According to the WHO, safe surgery saves lives, and the use of biosurgical products is an integral part of quality surgical care.
Healthcare providers are increasingly shifting toward comprehensive surgical care models that integrate advanced biomaterials, minimally invasive techniques, and evidence-based surgical protocols. The combination of biosurgical products with modern surgical technologies, including robotic-assisted surgery and minimally invasive techniques, is improving overall surgical outcomes and patient recovery.
Bone-Graft Substitutes Segment Dominates Due to High Orthopedic Procedure Volumes
Among product categories, Bone-Graft Substitutes represent the largest segment of the global biosurgery market due to the high volume of spinal fusion procedures, joint replacements, and orthopedic trauma surgeries across all regions. In the United States, over 1 million total joint arthroplasties are performed annually, including more than 540,000 total hip arthroplasties and over 1 million total knee arthroplasties. More than 400,000 spinal fusion procedures are performed each year.
According to the German Endoprosthesis Register (EPRD), 410,333 endoprosthetic procedures on hip or knee were performed in Germany in 2024, the highest number ever recorded. According to the National Health Commission of China, the country's surgical procedures have been growing rapidly, with surgical methods continuously improving. These products include demineralized bone matrix (DBM), synthetic bone grafts, and biologic grafts incorporating growth factors.
Surgical Sealants and Adhesives represent the fastest-growing product category, driven by increasing adoption of minimally invasive and robotic surgical techniques. These productsincluding fibrin sealants, synthetic polymer-based sealants, and protein-based adhesivesare used to seal tissue surfaces, prevent fluid and air leaks, and reinforce surgical anastomoses. The shift toward advanced surgical platforms creates new opportunities for surgical sealants and adhesives that can be delivered through small incisions.
Technological Innovation Transforming Biosurgery Product Adoption
Continuous innovation in biomaterials and surgical delivery systems is a major factor supporting biosurgery market growth. Manufacturers are focusing on developing products with improved safety, enhanced performance, and better clinical outcomes.
Key technological advancements include:
• Next-generation hemostatic agents with faster action times and improved handling characteristics
• Synthetic sealants with enhanced wet-tissue adhesion and faster polymerization times
• Bioactive bone grafts with regenerative capabilities and growth factors
• Absorbable adhesion barriers reducing the risk of postoperative adhesions
• Improved delivery systems enabling precise product application in minimally invasive procedures
• Advanced biomaterials with enhanced biocompatibility and reduced immunogenicity
• Sprayable formulations enabling application in laparoscopic and robotic procedures
The integration of digital health technologies is further transforming biosurgery care. Advanced manufacturing techniques including 3D printing are enabling the development of patient-specific implants and tissue-engineered constructs for reconstructive and orthopedic applications.
Cardiovascular Surgery Emerges as Fastest-Growing Application Segment
Cardiovascular Surgery represents the fastest-growing application area in the global biosurgery market, driven by the high prevalence of cardiovascular disease and the aging population. Vascular sealants, hemostatic agents, and soft-tissue attachments are increasingly utilized in cardiac and vascular procedures, including coronary artery bypass grafting, valve replacements, and vascular reconstructions.
Orthopedic Surgery remains the largest application area for biosurgical products globally, driven by the high volume of joint replacement, spinal fusion, and trauma procedures. The aging global population continues to drive demand for musculoskeletal interventions, with the global population aged 60 and older projected to reach 2.1 billion by 2050.
General Surgery encompasses a broad range of abdominal, gastrointestinal, and soft-tissue procedures, including bariatric surgery, colorectal surgery, and hernia repair. The high volume of general surgical procedures globally ensures consistent demand across all product categories.
Hospitals Lead End-User Adoption Due to Advanced Infrastructure
Hospitals represent the dominant end-user segment in the biosurgery market due to their ability to provide complex surgical procedures and comprehensive post-operative care. Biosurgical product utilization requires advanced operating rooms, specialized surgical teams, and comprehensive surgical infrastructure. These facilities are primarily available within tertiary hospitals, academic medical centers, and advanced healthcare institutions.
Regional Analysis
North America represents a major regional market for biosurgery, driven by advanced healthcare infrastructure, high surgical procedure volumes, robust reimbursement systems, and the presence of key market players. According to the U.S. Centers for Medicare & Medicaid Services (CMS), the agency substantially expanded the list of procedures outpatient surgery centers are allowed to perform, shifting more surgical procedures away from the traditional hospital setting. The United States performs approximately 40 million to 50 million major surgical procedures annually.
Asia-Pacific is expected to be a rapidly growing biosurgery market, driven by the region's massive surgical volumes, rapid healthcare infrastructure expansion, and large aging populations. According to the National Health Commission of China, the country's surgical procedures have been growing rapidly, with surgical methods continuously improving. Regulatory modernization across the region, including China's NMPA innovative device review process, Japan's PMD Act amendments, South Korea's Digital Medical Products Act, and India's National Medical Devices Policy, is facilitating faster market access for innovative biosurgical products.
Europe represents a mature biosurgery market with established healthcare systems. According to the German Federal Statistical Office (Destatis), 16,531,491 surgical procedures were performed on full inpatient hospital patients in Germany in 2023. Healthcare expenditure in Germany reached EUR 579.5 billion in 2025. According to the German Endoprosthesis Register (EPRD), 410,333 endoprosthetic procedures on hip or knee were performed in Germany in 2024, the highest number ever recorded. The regulatory environment, centered on the European Medical Device Regulation (MDR) and national competent authorities, plays a decisive role in shaping market dynamics.
South America represents a growing biosurgery market. According to the Brazilian Ministry of Health, the Unified Health System (SUS) performed 14.7 million elective surgeries in 2025, a record high. Brazil's elderly population (60 years and older) reached 16.6% of the total population in 2025, up from 11.3% in 2012. Colombia has achieved 99% healthcare coverage of its population.
The Middle East and Africa represent a developing biosurgery market. Saudi Arabia allocates substantial resources to healthcare, with total health expenditure exceeding SAR 175 billion annually. The UAE ranks first globally in 10 healthcare competitiveness indicators in the IMD World Competitiveness Yearbook 2026. South Africa's health spending reached 9.14% of GDP in 2025the highest on record.
Future Outlook
The global biosurgery market is expected to maintain strong growth through 2031 as healthcare systems continue prioritizing advanced surgical care and improved patient outcomes. Increasing adoption of minimally invasive surgery, robotic-assisted surgery, ambulatory surgical centers, and advanced biomaterials will continue transforming the biosurgery landscape.
The global population aged 60 and older is projected to reach 2.1 billion by 2050, driving sustained demand for surgical interventions. Expansion of healthcare infrastructure, improved physician training, and increasing accessibility to advanced surgical technologies in emerging economies will create additional opportunities for market expansion.
As the global burden of chronic diseases continues rising, biosurgical products will remain a critical component of modern surgical care by improving hemostasis, reducing complications, accelerating wound healing, and supporting long-term patient recovery worldwide.
Biosurgical products are widely used across multiple surgical specialties, including orthopedic surgery, general surgery, cardiovascular surgery, neurological surgery, reconstructive surgery, gynecological surgery, urological surgery, and thoracic surgery. These products are utilized among patients undergoing joint replacement, spinal fusion, trauma repair, cardiac procedures, and various other surgical interventions.
According to the research report, "Global Biosurgery Market Outlook, 2031," published by Bonafide Research, the Global Biosurgery Market is expected to cross USD 25.08 Billion market size by 2031, with 6.13% CAGR from 2026 to 2031. The global biosurgery market is projected to expand significantly during the forecast period from 2026 to 2031, supported by the rising global burden of chronic diseases, increasing surgical procedure volumes, growing elderly population, technological advancements in surgical biomaterials, and improving access to specialized surgical care.
According to the World Health Organization (WHO), an estimated 313 million surgical procedures are performed globally each year. Surgical conditions contribute to approximately 30% of the global burden of disease. According to the WHO, the global population aged 60 years and older is expected to reach 2.1 billion by 2050, significantly increasing demand for orthopedic and other surgical interventions. According to the International Diabetes Federation (IDF), approximately 537 million adults were living with diabetes globally in 2021, and this number is projected to rise to 643 million by 2030, directly increasing demand for biosurgery products in wound care and surgical management.
Rising Burden of Chronic Diseases and Surgical Procedures Driving Biosurgery Market Expansion
The increasing global prevalence of chronic diseases represents the primary growth driver for the biosurgery market. Aging populations across North America, Europe, and Asia-Pacific are contributing significantly to the rising number of patients requiring surgical interventions. Additionally, improvements in healthcare delivery have increased access to surgical care, resulting in a larger population undergoing surgical procedures globally.
Biosurgical products have become an essential component of modern surgical care by improving hemostasis, reducing postoperative complications, accelerating wound healing, and lowering the risk of surgical site infections among appropriately selected patients. According to the WHO, safe surgery saves lives, and the use of biosurgical products is an integral part of quality surgical care.
Healthcare providers are increasingly shifting toward comprehensive surgical care models that integrate advanced biomaterials, minimally invasive techniques, and evidence-based surgical protocols. The combination of biosurgical products with modern surgical technologies, including robotic-assisted surgery and minimally invasive techniques, is improving overall surgical outcomes and patient recovery.
Bone-Graft Substitutes Segment Dominates Due to High Orthopedic Procedure Volumes
Among product categories, Bone-Graft Substitutes represent the largest segment of the global biosurgery market due to the high volume of spinal fusion procedures, joint replacements, and orthopedic trauma surgeries across all regions. In the United States, over 1 million total joint arthroplasties are performed annually, including more than 540,000 total hip arthroplasties and over 1 million total knee arthroplasties. More than 400,000 spinal fusion procedures are performed each year.
According to the German Endoprosthesis Register (EPRD), 410,333 endoprosthetic procedures on hip or knee were performed in Germany in 2024, the highest number ever recorded. According to the National Health Commission of China, the country's surgical procedures have been growing rapidly, with surgical methods continuously improving. These products include demineralized bone matrix (DBM), synthetic bone grafts, and biologic grafts incorporating growth factors.
Surgical Sealants and Adhesives represent the fastest-growing product category, driven by increasing adoption of minimally invasive and robotic surgical techniques. These productsincluding fibrin sealants, synthetic polymer-based sealants, and protein-based adhesivesare used to seal tissue surfaces, prevent fluid and air leaks, and reinforce surgical anastomoses. The shift toward advanced surgical platforms creates new opportunities for surgical sealants and adhesives that can be delivered through small incisions.
Technological Innovation Transforming Biosurgery Product Adoption
Continuous innovation in biomaterials and surgical delivery systems is a major factor supporting biosurgery market growth. Manufacturers are focusing on developing products with improved safety, enhanced performance, and better clinical outcomes.
Key technological advancements include:
• Next-generation hemostatic agents with faster action times and improved handling characteristics
• Synthetic sealants with enhanced wet-tissue adhesion and faster polymerization times
• Bioactive bone grafts with regenerative capabilities and growth factors
• Absorbable adhesion barriers reducing the risk of postoperative adhesions
• Improved delivery systems enabling precise product application in minimally invasive procedures
• Advanced biomaterials with enhanced biocompatibility and reduced immunogenicity
• Sprayable formulations enabling application in laparoscopic and robotic procedures
The integration of digital health technologies is further transforming biosurgery care. Advanced manufacturing techniques including 3D printing are enabling the development of patient-specific implants and tissue-engineered constructs for reconstructive and orthopedic applications.
Cardiovascular Surgery Emerges as Fastest-Growing Application Segment
Cardiovascular Surgery represents the fastest-growing application area in the global biosurgery market, driven by the high prevalence of cardiovascular disease and the aging population. Vascular sealants, hemostatic agents, and soft-tissue attachments are increasingly utilized in cardiac and vascular procedures, including coronary artery bypass grafting, valve replacements, and vascular reconstructions.
Orthopedic Surgery remains the largest application area for biosurgical products globally, driven by the high volume of joint replacement, spinal fusion, and trauma procedures. The aging global population continues to drive demand for musculoskeletal interventions, with the global population aged 60 and older projected to reach 2.1 billion by 2050.
General Surgery encompasses a broad range of abdominal, gastrointestinal, and soft-tissue procedures, including bariatric surgery, colorectal surgery, and hernia repair. The high volume of general surgical procedures globally ensures consistent demand across all product categories.
Hospitals Lead End-User Adoption Due to Advanced Infrastructure
Hospitals represent the dominant end-user segment in the biosurgery market due to their ability to provide complex surgical procedures and comprehensive post-operative care. Biosurgical product utilization requires advanced operating rooms, specialized surgical teams, and comprehensive surgical infrastructure. These facilities are primarily available within tertiary hospitals, academic medical centers, and advanced healthcare institutions.
Regional Analysis
North America represents a major regional market for biosurgery, driven by advanced healthcare infrastructure, high surgical procedure volumes, robust reimbursement systems, and the presence of key market players. According to the U.S. Centers for Medicare & Medicaid Services (CMS), the agency substantially expanded the list of procedures outpatient surgery centers are allowed to perform, shifting more surgical procedures away from the traditional hospital setting. The United States performs approximately 40 million to 50 million major surgical procedures annually.
Asia-Pacific is expected to be a rapidly growing biosurgery market, driven by the region's massive surgical volumes, rapid healthcare infrastructure expansion, and large aging populations. According to the National Health Commission of China, the country's surgical procedures have been growing rapidly, with surgical methods continuously improving. Regulatory modernization across the region, including China's NMPA innovative device review process, Japan's PMD Act amendments, South Korea's Digital Medical Products Act, and India's National Medical Devices Policy, is facilitating faster market access for innovative biosurgical products.
Europe represents a mature biosurgery market with established healthcare systems. According to the German Federal Statistical Office (Destatis), 16,531,491 surgical procedures were performed on full inpatient hospital patients in Germany in 2023. Healthcare expenditure in Germany reached EUR 579.5 billion in 2025. According to the German Endoprosthesis Register (EPRD), 410,333 endoprosthetic procedures on hip or knee were performed in Germany in 2024, the highest number ever recorded. The regulatory environment, centered on the European Medical Device Regulation (MDR) and national competent authorities, plays a decisive role in shaping market dynamics.
South America represents a growing biosurgery market. According to the Brazilian Ministry of Health, the Unified Health System (SUS) performed 14.7 million elective surgeries in 2025, a record high. Brazil's elderly population (60 years and older) reached 16.6% of the total population in 2025, up from 11.3% in 2012. Colombia has achieved 99% healthcare coverage of its population.
The Middle East and Africa represent a developing biosurgery market. Saudi Arabia allocates substantial resources to healthcare, with total health expenditure exceeding SAR 175 billion annually. The UAE ranks first globally in 10 healthcare competitiveness indicators in the IMD World Competitiveness Yearbook 2026. South Africa's health spending reached 9.14% of GDP in 2025the highest on record.
Future Outlook
The global biosurgery market is expected to maintain strong growth through 2031 as healthcare systems continue prioritizing advanced surgical care and improved patient outcomes. Increasing adoption of minimally invasive surgery, robotic-assisted surgery, ambulatory surgical centers, and advanced biomaterials will continue transforming the biosurgery landscape.
The global population aged 60 and older is projected to reach 2.1 billion by 2050, driving sustained demand for surgical interventions. Expansion of healthcare infrastructure, improved physician training, and increasing accessibility to advanced surgical technologies in emerging economies will create additional opportunities for market expansion.
As the global burden of chronic diseases continues rising, biosurgical products will remain a critical component of modern surgical care by improving hemostasis, reducing complications, accelerating wound healing, and supporting long-term patient recovery worldwide.
Related Press Releases
Pediatric Medical Devices Market Accelerates with Rising Prevalence of Congenital Disorders.
Lifescience & Healthcare
Quick Contacts
Trusted Partners
Latest Press Release
We are friendly and approachable, give us a call.